Skip to main content
VulnerabilityPublished Updated

CVE-2026-96119: IBM i · Code Injection

Source CVE Database V5

0

Not known to be exploited · CVSS 9.9 Critical.

Data as of 26 Oct 2026, 14:05 UTC

CVSS 3.1 base score
9.9Critical
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.5% chance of exploitation in 30 days – higher than 43% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 12 Oct 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
IBMAffected
  • 7.3 – 7.6
4 affected builds
Fixed in–

CPE configurations (4)

  • cpe:2.3:a:ibm:i:7.6:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:i:7.5:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:i:7.4:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:i:7.3:*:*:*:*:*:*:*

AI-suggested

Until a fix is available, restrict access to the HTTP Server Administration web application to trusted users only and monitor for suspicious activity involving authenticated sessions.

Description

IBM i versions 7.3, 7.4, 7.5, and 7.6 contain a critical vulnerability (CVE-2026-96119) in the HTTP Server Administration web application. This flaw involves improper data sanitization that could allow a remote authenticated attacker to execute arbitrary code or obtain sensitive information on the affected system. The vulnerability is classified under CWE-94 (Improper Control of Generation of Code, also known as Code Injection).

References

Community reviews

Loading reviews…